We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protocol Published for Manufacture of 3D-Printed Probes for Research

By LabMedica International staff writers
Posted on 23 Aug 2018
Print article
Image: A three-dimensional (3D) printed microfluidic probe. Cube-shaped and green-colored, this probe is about the size of a ring box; however, the design can be printed in many sizes (Photo courtesy of NYU Abu Dhabi).
Image: A three-dimensional (3D) printed microfluidic probe. Cube-shaped and green-colored, this probe is about the size of a ring box; however, the design can be printed in many sizes (Photo courtesy of NYU Abu Dhabi).
A detailed protocol for producing microfluidic probes (MFPs) by simple three-dimensional (3D) printing was evaluated and made public for the general research community.

Currently, MFPs cannot be easily produced on demand due to their complex fabrication procedures and are expensive to manufacture in large quantities because of the assembly procedures that are required.

In a novel use of recent technical innovations, investigators at NYU Abu Dhabi (United Arab Emirates) fabricated MFPs in a single step by stereolithographic three-dimensional printing and benchmarked their performance compared to standard MFPs fabricated via glass or silicon micromachining.

Stereolithography is an additive manufacturing process that operates by focusing an ultraviolet (UV) laser on to a vat of photopolymer resin. With the help of computer aided manufacturing or computer-aided design (CAM/CAD) software, the UV laser is used to draw a pre-programmed design or shape on to the surface of the photopolymer vat. Photopolymers are sensitive to ultraviolet light, so the resin is photochemically solidified and forms a single layer of the desired three-dimensional object. Then, the build platform lowers one layer, and a blade recoats the top of the tank with resin.

In a paper published in the July 20, 2018, online edition of the journal Scientific Reports, the investigators highlighted the benefits of the method as well as the potential complications that arose during the process, and presented strategies for avoiding such complications. By presenting two different designs that used different approaches and focused on different aspects, the objective was to show the different design and fabrication possibilities, and hint at the broad applicability using virtually any moderate to high resolution printer. Effectiveness of the MFP’s performance was validated by evaluating standard staining of living adherent cells in Petri dishes.

The investigators have made their CAD files available to the general scientific community in order to enable researchers to test the “print & probe” approach using their own stereolithographic three-dimensional printers.

"Three-dimensional printers provide a simple, rapid, and low-cost technique for fabricating MFPs," said senior author Dr. Mohammad Qasaimeh, assistant professor of mechanical and biomedical engineering at NYU Abu Dhabi. "It is cheaper to produce, easy to scale up, and fast to fabricate -- all steps, from design to product, can be made in less than a day, and as a result, any science lab with a moderate resolution stereolithography printer will be able to fabricate three-dimensional MFPs on demand and use them to process cells reliably."

Related Links:
NYU Abu Dhabi

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.